Manuel Hildago

9PUBLICATIONS
62CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Nov 04, 2025
TRYBECA-1: A Randomized Phase III Study of Eryaspase Combined With Chemotherapy Versus Chemotherapy as Second-Line Treatment in Patients With Advanced Pancreatic Adenocarcinoma.

Pascal Hammel, Jean-Philippe Metges, Teresa Macarulla Mercade

|Nov 14, 2024
A Phase III Randomized Trial of Integrated Genomics and Avatar Models for Personalized Treatment of Pancreatic Cancer: The AVATAR Trial.

Francesca Sarno, Jair Tenorio, Sofia Perea

|Sep 21, 2023
Neoadjuvant botensilimab plus balstilimab response pattern in locally advanced mismatch repair proficient colorectal cancer.

Pashtoon Murtaza Kasi, Manuel Hidalgo, Mehraneh D Jafari

|Mar 27, 2023
A Preclinical and Phase Ib Study of Palbociclib plus Nab-Paclitaxel in Patients with Metastatic Adenocarcinoma of the Pancreas.

Manuel Hidalgo, Rocio Garcia-Carbonero, Kian-Huat Lim

|Jul 01, 2022
Facts and Hopes in Immunotherapy of Pancreatic Cancer.

Bruno Bockorny, Joseph E Grossman, Manuel Hidalgo

|Feb 12, 2022
VCN-01 disrupts pancreatic cancer stroma and exerts antitumor effects.

Miriam Bazan-Peregrino, Rocio Garcia-Carbonero, Berta Laquente

Pageof 2

Frequent Collaborators

3 joint publications

Rocio Garcia-Carbonero

3 joint publications

Bruno Bockorny

2 joint publications

Laura Medina Rodriguez

2 joint publications

Mariano Ponz-Sarvise